Last reviewed · How we verify

NCT03632902

Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysms

Completed Last updated 28 May 2020
What this trial tests

trial testing supraglottic device in Airway Management in 205 participants. Completed in 20 November 2019.

Timeline
26 June 2018
Primary endpoint
20 October 2019
20 November 2019

Quick facts

Lead sponsorFundacion Clinic per a la Recerca Biomédica
StatusCompleted
Study typeOBSERVATIONAL
Enrollment205
Start date26 June 2018
Primary completion20 October 2019
Estimated completion20 November 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacion Clinic per a la Recerca Biomédica

Who can join

Adults 18 to 90, any sex, with Airway Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endovascular techniques for the treatment of intracranial aneurysms are growing.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of second generation supraglottic airway device for endovascular treatment of unruptured intracranial aneurysms: a retrospective cohort.
    Hurtado P, Garcia-Orellana M, Amaro S, Carrero E, et al · · 2021 · cited 1× · PMID 33915196 · DOI 10.1016/j.bjane.2021.04.008

Verify or expand the search:

Other recruiting trials for Airway Management

Currently open trials in the same condition.

Other Fundacion Clinic per a la Recerca Biomédica trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03632902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing